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ABSTRACT  
 
Senescent cells secrete a combination of factors collectively known as the 
senescence-associated secretory phenotype (SASP). The SASP reinforces 
senescence and activates an immune surveillance response but it can also display 
pro-tumorigenic properties and contribute to age-related pathologies. In a drug 
screen to find novel SASP regulators, we uncovered the mTOR inhibitor rapamycin 
as a potent SASP suppressor. Here we report a mechanism by which mTOR controls 
the SASP by differentially regulating the translation of the MK2/MAPKAPK2 kinase 
through 4EBP1. In turn, MAPKAPK2 phosphorylates the RNA binding protein 
ZFP36L1 during senescence, inhibiting its ability to degrade the transcripts of 
numerous SASP components. Consequently, mTOR inhibition or constitutive 
activation of ZFP36L1 impairs the non-cell-autonomous effects of senescent cells 
both in tumour-suppressive and promoting-promoting contexts. Altogether, our 
results place regulation of the SASP as a key mechanism by which mTOR could 
influence cancer, age-related diseases and immune responses. 
 
 
